Technology ❯ Biotechnology ❯ mRNA Technology ❯ Vaccine Development

Clinical Trials

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

The study tests a fast‑to‑update mRNA shot to boost pandemic readiness against an evolving H5N1 threat.

FDA Reverses Course To Review Moderna’s mRNA Flu Shot Under Split Pathway

FDA Refuses to File Moderna’s mRNA Flu Vaccine Application Over Trial Comparator

HHS Cancels $500M in mRNA Vaccine Contracts, Winding Down Respiratory Virus Efforts

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial